Smith & Nephew plc Goodwill

The latest goodwill for SN.L is $3.2B as of June 2026. That compares with $3.1B in the prior-year period — up 4.1% year over year. Investors often review this figure alongside Smith & Nephew plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, SN.L's goodwill moved from $3.1B to $3.2B — a 4.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Smith & Nephew plc's operating scale or balance-sheet position.

A goodwill figure of $3.2B for SN.L is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SN.L's goodwill ($3.2B), review year-over-year change from $3.1B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Smith & Nephew plc's goodwill against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.